Linezolid tolerability in multidrug-resistant tuberculosis: A retrospective study

European Respiratory Journal

Volumn 46, Issue 4, 2015, Pages 1205-1207

  Bolhuis, Mathieu S ^a   Tiberi, Simon ^b   Sotgiu, Giovanni ^c   De Lorenzo, Saverio ^d   Kosterink, Jos G W ^a,e   Van Der Werf, Tjip S ^a   Migliori, Giovanni Battista ^f   Alffenaar, Jan Willem C ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b BARTS HEALTH NHS TRUST   (United Kingdom)

^c UNIVERSITY OF SASSARI   (Italy)

^d E Morelli Hospital   (Italy)

^e UNIVERSITY OF GRONINGEN   (Netherlands)

^f IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LINEZOLID; ANTIINFECTIVE AGENT;

ANEMIA; AREA UNDER THE CURVE; CUMULATIVE DRUG DOSE; DRUG BLOOD LEVEL; DRUG DOSE; DRUG EXPOSURE; DRUG SAFETY; DRUG TOLERABILITY; GASTROINTESTINAL SYMPTOM; HUMAN; LETTER; LEUKOPENIA; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANT TUBERCULOSIS; OPTIC NEURITIS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THROMBOCYTOPENIA; ADULT; CHEMICALLY INDUCED; CLINICAL TRIAL; DRUG ADMINISTRATION; FEMALE; ITALY; MALE; MIDDLE AGED; MULTICENTER STUDY; NETHERLANDS; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT;

ADULT; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; ITALY; LINEZOLID; MALE; MIDDLE AGED; NETHERLANDS; PERIPHERAL NERVOUS SYSTEM DISEASES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84943223093     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.00606-2015     Document Type: Letter

References (15)

1. Lee M, Lee J, Carroll MW, et al. Linezolid for Treatment of Chronic Extensively Drug-Resistant Tuberculosis. N Engl J Med 2012; 367: 1508-1518.
2. Tang S, Yao L, Hao X, et al. Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in China. Eur Respir J 2015; 45: 161-170.
3. Cox H, Ford N. Linezolid for the treatment of complicated drug-resistant tuberculosis: a systematic review and meta-analysis. Int J Tuberc Lung Dis 2012; 16: 447-454.
4. Sotgiu G, Centis R, D'Ambrosio L, et al. Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis. Eur Respir J 2012: 40; 1430-1442.
5. De Lorenzo S, Alffenaar JW, Sotgiu G, et al. Efficacy and safety of meropenem-clavunate added to linezolid-containing regimens in the treatment of M/XDR-TB. Eur Respir J 2013; 41: 1386-1392.
6. Bolhuis MS, van Altena R, van Soolingen D, et al. Clarithromycin increases linezolid exposure in multidrug-resistant tuberculosis patients. Eur Respir J 2013; 42: 1614-1621.
7. Srivastava S, Peloquin CA, Sotgiu G, et al. Therapeutic drug management: is it the future of multidrug-resistant tuberculosis treatment? Eur Respir J 2013; 42: 1449-1453.
8. Alffenaar JW, van Altena R, Harmelink IM, et al. Comparison of the pharmacokinetics of two dosage regimens of linezolid in multidrug-resistant and extensively drug-resistant tuberculosis patients. Clin Pharmacokinet 2010; 49: 559-565.
9. Singla R, Caminero JA, Jaiswal A, et al. Linezolid: an effective, safe and cheap drug for patients failing multidrug-resistant tuberculosis treatment in India. Eur Respir J 2012; 39: 956-962.
10. Bolhuis MS, Pranger AD, Alffenaar JW. Linezolid: safety and efficacy monitoring. Eur Respir J 2012; 39: 1275-1276.
11. Falzon D, Jaramillo E, Schünemann HJ, et al. WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J 2011; 38: 516-528.
12. De Vriese AS, Coster RV, Smet J, et al. Linezolid-induced inhibition of mitochondrial protein synthesis. Clin Infect Dis 2006; 42: 1111-1117.
13. Sotgiu G, Pontali E, Migliori GB. Linezolid to treat MDR-/XDR-tuberculosis: available evidence and future scenarios. Eur Respir J 2015; 45: 25-29.
14. Vu DH, Bolhuis MS, Koster RA, et al. Dried blood spot analysis for therapeutic drug monitoring of linezolid in patients with multidrug-resistant tuberculosis. Antimicrob Agents Chemother 2012; 56: 5758-5763.
15. Alffenaar JW, Kosterink JG, van Altena R, et al. Limited sampling strategies for therapeutic drug monitoring of linezolid in patients with multidrug-resistant tuberculosis. Ther Drug Monit 2010; 32: 97-101.